46274-54-8

Basic information

• Product Name: 1-Propanone, 3-(dimethylamino)-1-(2-methylphenyl)-
• CAS NO: 46274-54-8
• Molecular Formula: C12H17NO
• Molecular Weight: 191.273
• Mol File: 46274-54-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-Propanone, 3-(dimethylamino)-1-(2-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Propanone, 3-(dimethylamino)-1-(2-methylphenyl)-(46274-54-8)
• EPA Substance Registry System: 1-Propanone, 3-(dimethylamino)-1-(2-methylphenyl)-(46274-54-8)

Safety Data

• Hazardous Substances Data: 46274-54-8(Hazardous Substances Data)

Usage

Classification

Synthetic stimulant drug

Category

Cathinone class

Effects on the central nervous system

Increased alertness, euphoria, and a sense of heightened energy

Potential for abuse and addiction

High

Side effects

Paranoia, hallucinations, and agitation

Legal status

Banned in many countries, classified as a controlled substance in the United States

Form

White powder

Methods of ingestion

Ingestion, smoking, or injection

Health consequences

Serious and potentially dangerous

Upstream product

• 50-00-0 formaldehyd 
• 506-59-2 N,N-dimethylammonium chloride 
• 577-16-2 2-Methylacetophenone 

Downstream Products

• 653573-44-5 dimethyl-[3-(naphthalen-1-yloxy)-3-o-tolyl-propyl]-amine 
• 64632-63-9 3-dimethylamino-1-o-tolyl-propan-1-ol 

Relevant articles and documents

GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS

The present disclosure provides γ-diketones or analogs thereof, that activate Wnt/β-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.